Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cohort Study on Cardiovascular Risk in Type 2 Diabetes Mellitus Complicated With Metabolic Dysfunction-Associated Fatty Liver Disease

NCT07706010 is registered in ClinicalTrials.gov with The Affiliated Hospital of Hangzhou Normal University as lead sponsor.

NCT NCT07706010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07706010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cohort Study on Cardiovascular Risk in Type 2 Diabetes Mellitus Complicated With Metabolic Dysfunction-Associated Fatty Liver Disease
Lead sponsor
The Affiliated Hospital of Hangzhou Normal University
Phase
Observational
Overall status
Not yet recruiting
Start date
July 12, 2026
Completion date
May 29, 2031
Enrollment
7,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction-associated steatotic liver disease, type 2 diabetes (t2dm)